{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T17:41:06Z","timestamp":1659807666825},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment for peritoneal metastases from colorectal cancer (CRC) or pseudomyxoma peritonei (PMP). Because of the considerable morbidity of this treatment, optimal patient selection is key. This study aimed to assess the impact of low skeletal muscle mass (SMM) on outcomes after CRS-HIPEC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients who underwent CRS-HIPEC between 2014 and 2020 at a tertiary center were included. SMM was measured on computed tomography by means of the L3 muscle index. Postoperative complications and survival outcomes were compared between groups by use of logistic regression and Kaplan-Meier survival analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 284 included patients, 149 had low SMM. Occurrence of severe postoperative complications did not differ between groups (28.9% for patients with low vs. 34.1% for patients with normal SMM). Low SMM was not associated with postoperative complications (<jats:italic>p<\/jats:italic> = 0.344). For CRC patients, no significant differences were observed in disease-free (DFS) or overall survival (OS) between patients with low (median DFS 7 months [IQR 4\u201314], median OS 33 months [IQR 14\u2013NR]) and patients with normal SMM (median DFS 8 months [IQR 5\u201320], median OS 35 months [IQR 18\u2013NR]). Regarding PMP, survival outcomes did not significantly differ between groups (3-year DFS 47.3% for patients with low SMM vs. 54.5% for patients with normal SMM, <jats:italic>p<\/jats:italic> = 0.676; 3-year OS 70.8% vs. 90.9% respectively, <jats:italic>p<\/jats:italic> = 0.172).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Low SMM could not be identified as a predictor of severe complications or survival outcomes after CRS-HIPEC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-022-11941-2","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T17:02:58Z","timestamp":1654102978000},"page":"5830-5841","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"29","author":[{"given":"Michelle V.","family":"Dietz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job P.","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen L. A.","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra R. M.","family":"Brandt-Kerkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva V. E.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"issue":"20","key":"11941_CR1","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"V Verwaal","year":"2003","unstructured":"Verwaal V, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737\u201343. https:\/\/doi.org\/10.1200\/JCO.2003.04.187.","journal-title":"J Clin Oncol."},{"key":"11941_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","volume":"243","author":"M Koppe","year":"2006","unstructured":"Koppe M, Boerman OC, Oyen WJG, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243:212\u201322. https:\/\/doi.org\/10.1097\/01.sla.0000197702.46394.16.","journal-title":"Ann Surg."},{"issue":"9","key":"11941_CR3","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"V Verwaal","year":"2008","unstructured":"Verwaal V, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426\u201332.\u00a0https:\/\/doi.org\/10.1245\/s10434-008-9966-2.","journal-title":"Ann Surg Oncol."},{"key":"11941_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric french study. J Clin Oncol. 2010;28:63\u201386.\u00a0https:\/\/doi.org\/10.1200\/JCO.2009.23.9285.","journal-title":"J Clin Oncol."},{"issue":"2","key":"11941_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/s1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366. https:\/\/doi.org\/10.1016\/s1470-2045(20)30599-4.","journal-title":"Lancet Oncol."},{"issue":"20","key":"11941_CR6","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"T Chua","year":"2012","unstructured":"Chua T, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449\u201356. https:\/\/doi.org\/10.1200\/JCO.2011.39.7166.","journal-title":"J Clin Oncol."},{"key":"11941_CR7","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1245\/s10434-013-3223-z","volume":"21","author":"E Bartlett","year":"2014","unstructured":"Bartlett E, Meise C, Roses RE, Fraker DL, Kelz RR, Karakousis GC. Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database. Ann Surg Oncol. 2014;21:1494\u2013500. https:\/\/doi.org\/10.1245\/s10434-013-3223-z.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"11941_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1001\/jamasurg.2013.3640","volume":"149","author":"M Jafari","year":"2014","unstructured":"Jafari M, Halabi WJ, Stamos MJ, et al. Surgical outcomes of hyperthermic intraperitoneal chemotherapy. JAMA Surg. 2014;149(2):170\u20135. https:\/\/doi.org\/10.1001\/jamasurg.2013.3640.","journal-title":"JAMA Surg."},{"key":"11941_CR9","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"G Simkens","year":"2015","unstructured":"Simkens G, van Oudheusden TR, Luyer MD, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22:2656\u201362. https:\/\/doi.org\/10.1245\/s10434-014-4297-y.","journal-title":"Ann Surg Oncol."},{"key":"11941_CR10","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1245\/s10434-018-6823-9","volume":"25","author":"M Choudry","year":"2018","unstructured":"Choudry M, Shuai Y, Jones HL, et al. Postoperative complications independently predict cancer-related survival in peritoneal malignancies. Ann Surg Oncol. 2018;25:3950\u20139. https:\/\/doi.org\/10.1245\/s10434-018-6823-9.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"11941_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/jco.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539\u201347. https:\/\/doi.org\/10.1200\/jco.2012.45.2722.","journal-title":"J Clin Oncol."},{"key":"11941_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/bjs.9893","volume":"102","author":"S Levolger","year":"2015","unstructured":"Levolger S, van Vugt JLA, de Bruin RWF, IJzermans JNM. Systematic review of sarcopenia in patients operated on or gastrointestinal and hepatopancreatobiliary malignancies. Br J Surg. 2015;102:1448\u201358.\u00a0https:\/\/doi.org\/10.1002\/bjs.9893.","journal-title":"Br J Surg."},{"issue":"5","key":"11941_CR13","doi-asserted-by":"publisher","first-page":"E292","DOI":"10.1111\/ans.16706","volume":"91","author":"VW Chai","year":"2021","unstructured":"Chai VW, Chia M, Cocco A, Bhamidipaty M, D\u2019Souza B. Sarcopenia is a strong predictive factor of clinical and oncological outcomes following curative colorectal cancer resection. ANZ J Surg. 2021;91(5):E292\u20137. https:\/\/doi.org\/10.1111\/ans.16706.","journal-title":"ANZ J Surg."},{"issue":"4","key":"11941_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00423-020-01901-3","volume":"405","author":"D Schaffler-Schaden","year":"2020","unstructured":"Schaffler-Schaden D, Mittermair C, Birsak T, et al. Skeletal muscle index is an independent predictor of early recurrence in non-obese colon cancer patients. Langenbecks Arch Surg. 2020;405(4):469\u201377.\u00a0https:\/\/doi.org\/10.1007\/s00423-020-01901-3.","journal-title":"Langenbecks Arch Surg."},{"issue":"1","key":"11941_CR15","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1038\/s41598-020-65091-0","volume":"10","author":"S Wang","year":"2020","unstructured":"Wang S, Xie H, Gong Y, et al. The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep. 2020;10(1):8153. https:\/\/doi.org\/10.1038\/s41598-020-65091-0.","journal-title":"Sci Rep."},{"issue":"9","key":"11941_CR16","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.ejso.2018.05.029","volume":"44","author":"JLA van Vugt","year":"2018","unstructured":"van Vugt JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, et al. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol. 2018;44(9):1354\u201360.\u00a0https:\/\/doi.org\/10.1016\/j.ejso.2018.05.029.","journal-title":"Eur J Surg Oncol."},{"key":"11941_CR17","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1245\/s10434-015-4429-z","volume":"22","author":"J van Vugt","year":"2015","unstructured":"van Vugt J, Braam HJ, van Oudheusden TR, et al. Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2015;22:3625\u201331.\u00a0https:\/\/doi.org\/10.1245\/s10434-015-4429-z.","journal-title":"Ann Surg Oncol."},{"issue":"12","key":"11941_CR18","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1245\/s10434-016-5360-7","volume":"23","author":"S Chemama","year":"2016","unstructured":"Chemama S, Bayar MA, Lanoy E, et al. Sarcopenia is Associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2016;23(12):3891\u20138.\u00a0https:\/\/doi.org\/10.1245\/s10434-016-5360-7.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"11941_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/02656736.2017.1371342","volume":"34","author":"N Banaste","year":"2018","unstructured":"Banaste N, Rousset P, Mercier F, et al. Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. Int J Hyper. 2018;34(5):589\u201394. https:\/\/doi.org\/10.1080\/02656736.2017.1371342.","journal-title":"Int J Hyper."},{"key":"11941_CR20","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.ejso.2018.07.060","volume":"44","author":"A Galan","year":"2018","unstructured":"Galan A, Rousset P, Mercier F, et al. Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia. Eur J Surg Oncol. 2018;44:1818\u201323.\u00a0https:\/\/doi.org\/10.1016\/j.ejso.2018.07.060.","journal-title":"Eur J Surg Oncol."},{"key":"11941_CR21","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","volume":"20","author":"A Kuijpers","year":"2013","unstructured":"Kuijpers A, Mirck B, Aalbers AGJ, et al. Cytoreduction and HIPEC in The Netherlands: nationwide long-term outcome following the dutch protocol. Ann Surg Oncol. 2013;20:4224\u201330.\u00a0https:\/\/doi.org\/10.1245\/s10434-013-3145-9.","journal-title":"Ann Surg Oncol."},{"key":"11941_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00268-014-2801-y","volume":"39","author":"A Kuijpers","year":"2015","unstructured":"Kuijpers A, Aalbers AGJ, Nienhuijs SW, et al. Implementation of a standardized HIPEC protocol improves outcome for peritoneal malignancy. World J Surg. 2015;39:453\u201360.\u00a0https:\/\/doi.org\/10.1007\/s00268-014-2801-y.","journal-title":"World J Surg."},{"key":"11941_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.\u00a0https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23.","journal-title":"Cancer Treat Res."},{"issue":"2","key":"11941_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.\u00a0https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg."},{"key":"11941_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jcsm.12158","volume":"8","author":"J van Vugt","year":"2017","unstructured":"van Vugt J, Levolger S, Ghabharan A, et al. A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle. 2017;8:285\u201397.\u00a0https:\/\/doi.org\/10.1002\/jcsm.12158.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"11941_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","volume":"23","author":"G Simkens","year":"2016","unstructured":"Simkens G, van Oudheusden TR, Luyer MD, et al. Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2016;23:833\u201341.\u00a0https:\/\/doi.org\/10.1245\/s10434-015-4892-6.","journal-title":"Ann Surg Oncol."},{"key":"11941_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejso.2018.10.545","volume":"45","author":"A Oemrawsing","year":"2019","unstructured":"Oemrawsing A, de Boer NL, Brandt-Kerkhof ARM, Verhoef C, Burger JWA, Madsen EVE. Short-term complications in elderly patients undergoing CRS and HIPEC: A single center\u2019s initial experience. Eur J Surg Oncol. 2019;45:383\u20138.\u00a0https:\/\/doi.org\/10.1016\/j.ejso.2018.10.545.","journal-title":"Eur J Surg Oncol."},{"key":"11941_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-015-4624-y","volume":"22","author":"M Peters","year":"2015","unstructured":"Peters M, Bartlett EK, Roses RE, Kelz RR, Fraker DL, Karakousis GC. Age-related morbidity and mortality with cytoreductive surgery. Ann Surg Oncol. 2015;22:898\u2013904.\u00a0https:\/\/doi.org\/10.1245\/s10434-015-4624-y.","journal-title":"Ann Surg Oncol."},{"key":"11941_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/bjc.2012.350","volume":"107","author":"J Lieffers","year":"2012","unstructured":"Lieffers J, Bathe OF, Fassbender K, Winget M, Baraco VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107:931\u20136.\u00a0https:\/\/doi.org\/10.1038\/bjc.2012.350.","journal-title":"Br J Cancer."},{"key":"11941_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/SLA.0000000000000628","volume":"261","author":"K Reisinger","year":"2015","unstructured":"Reisinger K, van Vugt JLA, Tegels JJW, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg. 2015;261:345\u201352.\u00a0https:\/\/doi.org\/10.1097\/SLA.0000000000000628.","journal-title":"Ann Surg."},{"key":"11941_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"C Prado","year":"2008","unstructured":"Prado C, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629\u201335.\u00a0https:\/\/doi.org\/10.1016\/S1470-2045(08)70153-0.","journal-title":"Lancet Oncol."},{"issue":"5","key":"11941_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395.\u00a0https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7.","journal-title":"Lancet Oncol."},{"issue":"1","key":"11941_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1245\/s10434-020-08619-y","volume":"28","author":"JP van Kooten","year":"2021","unstructured":"van Kooten JP, Oemrawsingh A, de Boer NL, et al. Predictive ability of c-reactive protein in detecting short-term complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cross-sectional study. Ann Surg Oncol. 2021;28(1):233\u2013243. https:\/\/doi.org\/10.1245\/s10434-020-08619-y.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"11941_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1754-9493-4-5","volume":"4","author":"P Kirchhoff","year":"2010","unstructured":"Kirchhoff P, Clavien PA, Hahnloser D. Complications in colorectal surgery: risk factors and preventive strategies. Patient Saf Surg. 2010;4(1):5. https:\/\/doi.org\/10.1186\/1754-9493-4-5.","journal-title":"Patient Saf Surg."},{"issue":"7","key":"11941_CR35","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1445-2197.2006.03780.x","volume":"76","author":"M Lipska","year":"2006","unstructured":"Lipska M, Bissett IP, Parry BR, Merrie AEH. Anastomotic leakage after lower gastrointestinal anastomosis: men are at higher risk. ANZ J Surg. 2006;76(7):579\u201385. https:\/\/doi.org\/10.1111\/j.1445-2197.2006.03780.x.","journal-title":"ANZ J Surg."},{"issue":"5","key":"11941_CR36","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0000000000002398","volume":"266","author":"JA Elliott","year":"2017","unstructured":"Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266(5):822\u201330. https:\/\/doi.org\/10.1097\/SLA.0000000000002398.","journal-title":"Ann Surg."},{"issue":"13","key":"11941_CR37","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1245\/s10434-015-4558-4","volume":"22","author":"KW Reisinger","year":"2015","unstructured":"Reisinger KW, Bosmans JWAM, Uittenbogaart M, et al. Loss of skeletal muscle mass during neoadjuvant chemoradiotherapy predicts postoperative mortality in esophageal cancer surgery. Ann Surg Oncol. 2015;22(13):4445\u201352. https:\/\/doi.org\/10.1245\/s10434-015-4558-4.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"11941_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clnu.2011.08.008","volume":"31","author":"S Awad","year":"2012","unstructured":"Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 2012;31(1):74\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.clnu.2011.08.008.","journal-title":"Clin Nutr."},{"issue":"4","key":"11941_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412\u201323.\u00a0https:\/\/doi.org\/10.1093\/ageing\/afq034.","journal-title":"Age Ageing."},{"issue":"1","key":"11941_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019;48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169.","journal-title":"Age and Ageing."},{"issue":"3","key":"11941_CR41","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s10120-015-0554-4","volume":"19","author":"T Sato","year":"2016","unstructured":"Sato T, Aoyama T, Hayashi T, et al. Impact of preoperative hand grip strength on morbidity following gastric cancer surgery. Gastric Cancer. 2016;19(3):1008\u201315. https:\/\/doi.org\/10.1007\/s10120-015-0554-4.","journal-title":"Gastric Cancer."},{"issue":"7\u20138","key":"11941_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/ans.14325","volume":"88","author":"A Chandoo","year":"2018","unstructured":"Chandoo A, Chi C-H, Ji W, et al. Gait speed predicts post-operative medical complications in elderly gastric cancer patients undergoing gastrectomy. ANZ J Surg. 2018;88(7\u20138):723\u20136. https:\/\/doi.org\/10.1111\/ans.14325.","journal-title":"ANZ J Surg."},{"key":"11941_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.clnesp.2020.11.009","volume":"41","author":"K Tanaka","year":"2021","unstructured":"Tanaka K, Taoda A, Kashiwagi H. The associations between nutritional status, physical function and skeletal muscle mass of geriatric patients with colorectal cancer. Clin Nutr ESPEN. 2021;41:318\u201324. https:\/\/doi.org\/10.1016\/j.clnesp.2020.11.009.","journal-title":"Clin Nutr ESPEN."},{"issue":"8","key":"11941_CR44","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/jso.26652","volume":"124","author":"MA West","year":"2021","unstructured":"West MA, Baker WCA, Rahman S, et al. Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection. J Surg Oncol. 2021;124(8):1306\u201316. https:\/\/doi.org\/10.1002\/jso.26652.","journal-title":"J Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11941-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11941-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T17:12:09Z","timestamp":1659805929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11941-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11941"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11941-2","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The race\/ethnicity distribution was not reported, as this data was not collected in the database that was analyzed for this study. As this is a retrospective study, this data could not be obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Race\/Ethnicity Data"}}]}}